DS3 - REGORAFENIB IN METASTATIC COLORECTAL CANCER- COST-EFFECTIVENESS ANALYSIS BASED ON PROPENSITY SCORE WEIGHTED COHORT OF CZECH REGISTRY
Oct 1, 2018, 00:00
10.1016/j.jval.2018.09.044
https://www.valueinhealthjournal.com/article/S1098-3015(18)33344-8/fulltext
Title :
DS3 - REGORAFENIB IN METASTATIC COLORECTAL CANCER- COST-EFFECTIVENESS ANALYSIS BASED ON PROPENSITY SCORE WEIGHTED COHORT OF CZECH REGISTRY
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(18)33344-8&doi=10.1016/j.jval.2018.09.044
First page :
Section Title :
Open access? :
No
Section Order :
2371